Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

F099 - Wound Closure Design: Basic to Advanced

Sunday, February 18; 1:00 PM - 3:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Differentiate between a variety of methods to close wounds after skin cancer removal
  • Recognize pitfalls in wound closure and how to optimize wound closure methods for best cosmetic results in patient healing.
  • Discuss the subtleties of design to maximize healing.

Description

Wound closure after skin cancer removal is often the most exciting and artistic part of dermatologic surgery. This session will allow participants to learn basic and advanced skills in suturing and closure design including flaps and grafts.

Disclosures

  • Cronin, Terrence A., Jr., MD: no financial relationships exist with commercial interests.
  • Kantor, Jonathan, MD: Abbott Laboratories – I(OB); Allergan, Inc – I(OB); Asubio Pharmaceuticals, Inc. – I(OB); Celgene Corporation – I(OB); Idera Pharmaceuticals, Inc. – I(OB); Janssen-Ortho Inc. – I(OB); Kythera – I(OB); LEO Pharma, US – I(OB); McGraw-Hill Companies – O(IP); Pfizer Inc. – I(OB); Taro Pharm – I(OB); Tolmar – I(OB);
  • Weinkle, Susan H., MD: Allergan, Inc – C(H), I(H); Allergan, Inc. – A(H), SP(H); Alphaeon – I(H); Derm Advance – I(NC), SH(NC); Ethicon, Inc. – A(H), C(H), SP(H); Galderma Laboratories, L.P. – C(H), SP(H); Merz Aesthetics – A(H), C(H), SP(H); Procter & Gamble Company – C(H); Sinclair Pharma – C(H), I(H); TEOXANE Laboratories – I(H);
  • Weinstein, Andrew Hart, MD, MPH: no financial relationships exist with commercial interests.
Event Details
  • Date
    Sunday, February 18
  • Time
    1:00 PM - 3:00 PM
  • Location
    Room 32B
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
  • Terrence A. Cronin, Jr., MD, FAAD
Speakers
  • Andrew Hart Weinstein, MD, MPH, FAAD
  • Jonathan Kantor, MD, FAAD
  • Susan H. Weinkle, MD, FAAD